652
Views
4
CrossRef citations to date
0
Altmetric
Editorial

PDGF receptor blocker for pulmonary hypertension: a new agent in therapeutic arsenal

, MD
Pages 139-142 | Published online: 05 Jan 2012

Figures & data

Figure 1. Initial injury leads to the loss or dysfunction of endothelial caveolin-1 and increased expression of PDGF-BB. This figure depicts the possible PDGF-mediated pathways and the sites of inhibitory activity of imatinib.

Figure 1. Initial injury leads to the loss or dysfunction of endothelial caveolin-1 and increased expression of PDGF-BB. This figure depicts the possible PDGF-mediated pathways and the sites of inhibitory activity of imatinib.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.